TOKYO, Oct 8, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received approval for "URECE Tablets" (dotinurad) in Thailand as a treatment for gout and hyperuricemia. This ...
TOKYO, Jul 14, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has launched "URECE" (brand name in China: "Youlesi", generic name: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback